Clinical trial · Observational
Epstein-Barr Virus and Cancer Risks
Prospective Cohort Study on Epstein-Barr Virus Antibody and Cancer Risks
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The goal of this prospective cohort study is to investigate the associations between Epstein-Barr Virus (EBV) antibody levels and the risk of overall and site-specific cancer types in Southern China. The main questions it aims to answer are: Question 1: In addition to the established EBV-associated cancer types, such as lymphomas, nasopharyngeal carcinoma, and stomach cancer, whether EBV is associated with other cancer types? Question 2: What's the cancer burden attributed to EBV in Southern China?
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Diagnostic test: EBV antibody tests | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Zhongshan cohort, Guangdong, China
- description
- 30-59 years old healthy participants in Zhongshan city.
- interventionNames
- Other: Diagnostic test: EBV antibody tests
- label
- Wuzhou cohort, Guangxi, China
- description
- 30-69 years old healthy participants in Wuzhou city.
- interventionNames
- Other: Diagnostic test: EBV antibody tests
Primary outcomes (1)
- measure
- Cancer incidence
- timeFrame
- 10 years
- description
- The primary outcome of the study was the diagnosis of any type of cancer. The cancer type for each participant was defined as their initial and primary cancer diagnosis.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 30 Years
- Maximum age
- 69 Years
Show eligibility criteria text
Inclusion Criteria: * Subject residents in Zhongshan or Wuzhou City; * Subject has no medical record of prevalent cancer; * Subject has psychical condition and well consciousness, and willingness to accept and cooperate with the study\'s follow-up procedures. Exclusion Criteria: * Subject has heavy cardiovascular, liver, or kidney disease; * Subject has prevalent cancer.
References
Publications (0)
Data not yet available